Kinled Holding
Investment company wholly owned by the Anglo-Austrian Aisher family; backs life-science, digital and fintech ventures directly and via funds, with co-investment from others.
USEFUL FOR Fund managers raising capital · Co-investors
Family & background
- FAMILY
- Aisher
- WEALTH ORIGIN
- Industrial businesses (building materials, plastics, automotive components) built over four generations
- HEADQUARTERS
- Hong Kong, Hong Kong
- OFFICES
- Switzerland · Austria · Gibraltar · London · Shanghai
- FOUNDED
- 1924
- OUTSIDE CAPITAL
- Yes — also manages others' money
Investment approach
- GEOGRAPHY
- EuropeUnited States
- ROUTES
- Companies (own capital) · Funds (as LP)
- STRATEGIES
- Direct investmentsVenture capitalFunds (as LP)
Overview
Kinled Holding describes itself as a privately held investment company wholly owned and managed by the Anglo-Austrian Aisher family, active since 1924, with offices in Hong Kong, London, Gibraltar and Vienna. It says it holds about 175 investments directly and through specialised funds, with over half in life sciences (medical devices, robotics, neuromodulation, precision medicine) and the rest in digital technology and fintech, many spun out of universities in Austria, Switzerland, Europe and the US. It is a founding partner or LP in ten venture funds, manages two EU-regulated funds and offers qualified individuals and family offices co-investment through its Private Client division. Chairman Patrick Aisher rejects the family-office label.
Investment thesis
Patient, long-term capital to turn academic and scientific projects into commercial businesses, in life sciences, digital technology and fintech.
Holdings & investments (8)
People
- Patrick AisherChairman and CEO · source
Frequently asked questions
Kinled Holding is a family-anchored fund based in Hong Kong, Hong Kong, founded in 1924.
Kinled Holding invests on behalf of the Aisher family (Industrial businesses (building materials, plastics, automotive components) built over four generations).
Kinled Holding invests its own capital into companies and in third-party funds as an LP. Its stated asset mix includes direct investments, venture capital and funds (as lp).
Kinled Holding invests in Biotech & Life Sciences, HealthTech, Fintech, Software & SaaS and Deep Tech.
Key people at Kinled Holding include Patrick Aisher (Chairman and CEO).
Kinled Holding's holdings and investments include Speedinvest, Maki.vc, Concentric, D2 Fund, Verve Ventures, Danube Labs, Danube Neuro and Pureos Bioventures.
Yes. Kinled Holding manages capital from outside investors.